PRIME: PReservIng Memory in Epilepsy
NCT: NCT05608408 · RECRUITING
Brief Summary
In this study, participants will receive unilateral Deep Brain Stimulation (DBS) for treatment of epilepsy, with network-based stimulation targets specifically defined using a stereo-electro-encephalographic evaluation and chronic recordings using the Medtronic Percept™ primary cell (PC) Neurostimulator DBS System with BrainSense™ Technology. The hypothesis is that, compared to no stimulation or to standard duty cycle high frequency stimulation, epilepsy neuromodulation using low frequency stimulation and informed by network architecture in patients with epilepsy that arises in a hippocampus that also subserves memory - epilepsy in a precious hippocampus (EPH) - will result in a significant decrease in seizure frequency and severity, paralleled by a decrease in EEG spike counts and improved memory function.
Frequently Asked Questions
What is PRIME: PReservIng Memory in Epilepsy?
PRIME: PReservIng Memory in Epilepsy is a clinical trial registered under NCT05608408. Current status: RECRUITING.
What is the status of NCT05608408?
The current status of NCT05608408 (PRIME: PReservIng Memory in Epilepsy) is: RECRUITING.
When did PRIME: PReservIng Memory in Epilepsy start?
PRIME: PReservIng Memory in Epilepsy started on 2023-11-16.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.